Compare Amylx Pharmaceuticals Inc (AMLX) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Reddit Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.58 (market cap $2.64B), while Reddit Inc trades at $153.83 (market cap $30.05B). The key difference: Reddit Inc is far larger — about 11.4× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | RDDT | |
|---|---|---|
Market Cap | $2.64B | $30.05B |
Sector | Health | Media |
52-Week High | $24.19 | $270.71 |
52-Week Low | $7.82 | $121.84 |
Enterprise Value | $2.39B | $27.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMLX trades at $23.66, up 4.37% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$144.74M in 2025, with negative ROE and ROA, while Q2 2026 EPS missed expectations. Key catalysts include the Phase 3 LUCIDITY trial readout for avexitide expected in late August or early September 2026, as highlighted in recent earnings calls and news.
Analyst consensus is strongly bullish with a $30.00 price target and 91% buy ratings, driven by pipeline potential. However, high cash burn, ongoing losses, and reliance on clinical trial success pose significant risks. The stock offers speculative upside if trials succeed but faces downside from operational challenges and market volatility.
Reddit (RDDT) trades at $154.14, down 2.87% over 24 hours, amid bearish technical signals despite strong fundamentals. The stock shows robust revenue growth, with Q2 2026 earnings beating estimates by 31.6% and a net income margin of 31.35%. Recent news highlights CEO stock sales and AI integration efforts, while technical indicators point to resistance near $160.
Outlook remains positive based on analyst consensus with a $220.25 price target, though risks include search traffic volatility and competitive pressures. The stock's current valuation offers potential upside if user monetization and AI initiatives drive future earnings, but investors should monitor quarterly performance for sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
